PROTEIN EXPRESSION AND BISPECIFIC ANTIBODIES
PROTEIN EXPRESSION AND BISPECIFIC ANTIBODIES
批准号:
6161120
负责人:
David M. Segal
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have previously used bispecific antibodies (bsAb) to redirect
cytotoxic cells against tumor and other target cells and to study
triggering mechanisms. In a collaboration with GenVec, we are developing
a new application for bsAbs, the selective targeting of cells for
adenovirus infection. A bsAb with anti-CD3 and anti-FLAG activity
induces the infection of human T cell with adenovirus that contains a
genetically introduced FLAG peptide and expresses - galactosidase as a
reporter gene. T cells are not infected without the bsAb, both CD4 and
CD8 T cells are infected, and CD3- cells are not infected. Other bsAbs
are being produced to see which types of molecules on cell surfaces can
be used to induce bsAb dependent infections. BsAb directed infection
could prove important for gene therapy applications.
We have produced single chain (sc) bsAbs by concatenating two scFvs.
These molecules are secreted as active protein by mammalian cells, or
are produced by bacteria and refolded in vitro. We have found that
inclusion of a glycosylation site on an anti-DNP scFv enhances its rate
of secretion, without affecting its stability. More recently we have
found that in the ER, the glycosylation site increases the rate of
protein folding as measured by the appearance of anti-DNP binding
activity. Preliminary studies, in collaboration with Kelly Kearse,
showed that the glycosylated form of the scFv binds calnexin. We will
use this system to see if calnexin aids the scFv in gaining anti-DNP
activity.
In our studies of in vitro protein folding we found that proteins that
are normally secreted require special procedures for producing a native
molecule. To see how a cytoplasmic protein would fold in vitro, we, in
collaboration with Charles Zacharchuk, expressed the cytoplasmic portion
of bcl-2 as inclusion bodies in bacteria. We found that after
denaturation with guanidine and dialysis, the bcl-2 protein adopted a
biologically active form that consisted of 2 non-covalently interacting
regions separated by a long, exposed, protease-sensitive loop. The
hydrodynamic properties of bcl-2 suggest that its structure is similar
to the recently published X- ray structure of bcl-x. This first example
suggests that cytoplasmic proteins adopt their native configuration more
readily than secreted ones. Formerly Z01 CB 10028-01 EIB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTIVATION AND TRIGGERING OF EFFECTOR CELLS
-
批准号:6289236
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
Innate Immunity
-
批准号:6762137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
PROTEIN EXPRESSION AND BISPECIFIC ANTIBODIES
-
批准号:2463823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
Innate Immunity
-
批准号:6433138
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
Structure and Function of Toll-like Receptors
-
批准号:7732935
-
项目类别:
-
资助金额:$65.89万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
Innate Immunity
-
批准号:6559040
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
Innate Immunity
-
批准号:7592594
-
项目类别:
-
资助金额:$108.05万
-
财政年份:--
-
负责人:David M. Segal
-
依托单位:
海外基金